InflammaPain
InflammaPain, licence 80088273: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Robert Lamberton Consulting
- NPN or DIN-HM
- 80088273
- Status
- Active licence
- Licence date
- 7 September 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
- Conditions légales
Andrographis paniculata (Burm. f.) Nees: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serratiopeptidase Source : Serratia marcescens E-15 - Cellule Entiière | 100.0 milligramme | Not calculated |
| 1-[(2E, 4E)-5-(1,3-Benzodioxole-5-yl)-1-oxo-2,4-pentadiényl] pipéridine Source : Piper nigrum - fruit | 2.5 milligramme | Not calculated |
| Piscidia piscipula Source : Écorce de racine Extract : Matériel brut sec Extraction ratio : 1.5:1 Dry plant equivalent : 150 mg | 100.0 milligramme | Not calculated |
| Eschscholzia californica Source : Sommité | 100.0 milligramme | Not calculated |
| Astragalus membranaceus Source : Racine | 25.0 milligramme | Not calculated |
| Panax ginseng Source : Racine | 25.0 milligramme | Not calculated |
| Andrographis paniculata Source : Sommité | 150.0 milligramme | Not calculated |
| Boswellia serrata Source : Gum oleoresin Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 100 mg Potency : 65.0 % Boswellic acids | 50.0 milligramme | Not calculated |
| Serratiopeptidase Source : Serratia marcescens E-15 - Cellule Entiière | 2500.0 SU | Not calculated |
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 150.0 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 50.0 milligramme | Not calculated |
| Zingiber officinale Source : Rhizome Potency : 5.0 % Total gingerols | 100.0 milligramme | Not calculated |
| Prunus cerasus Source : Fruit | 50.0 milligramme | Not calculated |
| Bromélaïne de tige Source : Ananas comosus var. comosus - Tige | 1800000.0 Unités de papaïne du FCC | Not calculated |
Non-medicinal ingredients
Gomme de cellulose, Hydroxyméthyl cellulose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | minimum: 1.0 Tous les jours ; maximum: 2.0 Tous les jours |
Uses authorised in Canada
Bromelain is used in herbal medicine to help relieve minor pain, swelling and inflammation (anti-inflammatory). Source of antioxidant(s) that help(s protect (cell) against (cell damage caused by) free radicals. Proteolytic Enzyme.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Allergic reaction has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhoea, abdominal pain, sweating, salivation heartburn, nausea and vomiting; in which case, discontinue use. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness. If you experience headache, discontinue use.
- Précautions et mises en garde
Keep out of the reach of children. If you are taking antiplatelet medication or blood thinners, consult a health care practitioner prior to use. If you have gallstones or a bile duct obstruction, consult a health care practitioner prior to use. If you have a gastrointestinal lesion/ ulcer, are taking an anticoagulant/blood thinner, anti-inflammatory or antibiotic, or are having surgery, consult a health care practitioner prior to use. Consumption with alcohol, other drugs or natural health products with sedative and/or analgesic properties is not recommended. Consult a health care practitioner prior to use if you have stomach ulcers or excess stomach acid. Consult a health care practitioner if symptoms persist or worsen. Do not use if you are breastfeeding. Consult a health care practitioner prior to use if you have hypertension as Jamaica dogwood may increase blood pressure. Jamaica dogwood has sedative effects, and may increase the effects of other drugs or herbs used for insomnia or anxiety (called central nervous system depressants). If you are using Jamaica dogwood, discontinue use at least two weeks prior to surgery. If you re taking any other medications or natural health products, consult a health care practitioner prior to use, as piperine may alter their effectiveness. Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Consult a health care practitioner prior to use if you have an auto-immune disorder. If you have excess gastric acidity, or oesophageal reflux, consult a health care practitioner prior to use. Do not use if you have bradycardia (slow heart beat) or cardiac insufficiency. Do not use if over the age of 65. Consult a health care practitioner prior to use if you are taking immunosuppressants. Consult a health care practitioner prior to use if you are trying to conceive.
- Contre-indications
Do not use if you are pregnant. Not recommended for use with children. Avoid in people with breathing disorders due to Jamaica dogwood.
Source
Official Health Canada record, licence 80088273
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.